Marios Giannakis

26PUBLICATIONS
326CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersHaematological tumoursCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (26)

|Jul 23, 2026
Copanlisib in combination with nivolumab formicrosatellite stable colorectal cancer: a phase 1/2 trial.

|May 25, 2026
Gemcitabine and nab-paclitaxel with or without the VDR agonist paricalcitol for metastatic pancreatic cancer: a randomized, multiarm, run-in phase trial.

|Apr 01, 2026
TGF-β Pathway-Based Polygenic Risk Score Modifies the Association between Red Meat Intake and Colorectal Cancer Risk: Application of a Novel Pathway-Based PRS Method.

Joel Sanchez Mendez, Bryan Queme, Yubo Fu

|Feb 13, 2026
A Phase II Trial of Niraparib in Patients with Advanced Pancreatic Cancer Harboring Pathogenic Variants in ATM, BRCA1, BRCA2, PALB2, and CHEK2.

Brandon M Huffman, Miklos Diossy, Matthew B Yurgelun

|Dec 19, 2025
Germline Predisposition to Oncogenic Alkylating Damage in Colorectal Cancer.

Carino Gurjao, Jules Cazaubiel, Chichun Tan

|Nov 12, 2025
T-cell Subset Features and Distributions Evolve across the Colorectal Precancer-Cancer Spectrum.

Yasutoshi Takashima, Andressa Dias Costa, Naohiko Akimoto

Pageof 5

Frequent Collaborators

10 joint publications

Kimmie Ng

9 joint publications

Jonathan A Nowak

9 joint publications

Harshabad Singh

8 joint publications

Benjamin Schlechter